HopeStage
Back to all studies
CompletedNCT00136760

Bupropion and vouchers to support smoking cessation in schizophrenia

About this titleRead the official source — NCT00136760
Medication studyAges 18–80United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 80 years.

Listed locations
ProvidenceSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2003
Recruitment status
Completed
Enrollment listed in the registry
57
Sponsor
Brown University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT00136760
Official title
Show the full official title

Incentives Plus Bupropion for Smoking in Schizophrenics

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Providence

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Brown University, a university.

Did this study involve medication?

Yes. The study involved medication, including Bupropion, Contingent reinforcement plus placebo, non-contingent reinforcement plus bupropion and Non-contingent reinforcement plus placebo.

Who was this study for?

Listed age limits: 18 years to 80 years.

Want to explore more studies?

Explore studies